Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat.

Hepatology research : the official journal of the Japan Society of Hepatology

Fukumoto Y, Murakami F, Tateishi A, Itoh Y, Sakaida I, Okita K.
PMID: 11882418
Hepatol Res. 2002 Mar;22(3):214-222. doi: 10.1016/s1386-6346(01)00141-3.

Secretin, a gastrointestinal hormone, is known to act on bile duct epithelial cells and has been thought to have no effects on the bile acid transport in the liver. However, secretin was proved recently to stimulate biliary secretion of...

Cite
Fukumoto Y, Murakami F, Tateishi A, et al. Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat. Hepatol Res. 2002;22(3):214-222doi: 10.1016/s1386-6346(01)00141-3.
Fukumoto, Y., Murakami, F., Tateishi, A., Itoh, Y., Sakaida, I., & Okita, K. (2002). Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat. Hepatology research : the official journal of the Japan Society of Hepatology, 22(3), 214-222. https://doi.org/10.1016/s1386-6346(01)00141-3
Fukumoto, Yohei, et al. "Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat." Hepatology research : the official journal of the Japan Society of Hepatology vol. 22,3 (2002): 214-222. doi: https://doi.org/10.1016/s1386-6346(01)00141-3
Fukumoto Y, Murakami F, Tateishi A, Itoh Y, Sakaida I, Okita K. Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat. Hepatol Res. 2002 Mar;22(3):214-222. doi: 10.1016/s1386-6346(01)00141-3. PMID: 11882418.
Copy Download .nbib Format: NLM
Vectorial transport of bile acids in immortalized mouse bile duct cells.

Hepatology research : the official journal of the Japan Society of Hepatology

Kida M, Mano Y, Ueno Y, Kobayashi K, Goto J, Ishii M, Shimosegawa T.
PMID: 14563430
Hepatol Res. 2003 Oct;27(2):151-157. doi: 10.1016/s1386-6346(03)00201-8.

In ileal epithelial cells, apical sodium-dependent bile acid transporter (ASBT) is responsible for the uptake of bile acids from the lumen. Furthermore, ASBT is expressed in the apical plasma membrane of intrahepatic bile duct cells (BECs). Using cultured immortalized...

Cite
Kida M, Mano Y, Ueno Y, et al. Vectorial transport of bile acids in immortalized mouse bile duct cells. Hepatol Res. 2003;27(2):151-157doi: 10.1016/s1386-6346(03)00201-8.
Kida, M., Mano, Y., Ueno, Y., Kobayashi, K., Goto, J., Ishii, M., & Shimosegawa, T. (2003). Vectorial transport of bile acids in immortalized mouse bile duct cells. Hepatology research : the official journal of the Japan Society of Hepatology, 27(2), 151-157. https://doi.org/10.1016/s1386-6346(03)00201-8
Kida, Mami, et al. "Vectorial transport of bile acids in immortalized mouse bile duct cells." Hepatology research : the official journal of the Japan Society of Hepatology vol. 27,2 (2003): 151-157. doi: https://doi.org/10.1016/s1386-6346(03)00201-8
Kida M, Mano Y, Ueno Y, Kobayashi K, Goto J, Ishii M, Shimosegawa T. Vectorial transport of bile acids in immortalized mouse bile duct cells. Hepatol Res. 2003 Oct;27(2):151-157. doi: 10.1016/s1386-6346(03)00201-8. PMID: 14563430.
Copy Download .nbib Format: NLM
A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis.

Amino acids

Malek Mahdavi A, Javadivala Z.
PMID: 33929638
Amino Acids. 2021 Jun;53(6):783-800. doi: 10.1007/s00726-021-02988-8. Epub 2021 Apr 30.

Due to the undesirable effects of conventional medical therapies prescribed for rheumatoid arthritis (RA), complementary therapies, especially nutritional agents, have recently gained great attention. Recent animal and in vitro researches have shown benefits of taurine (Tau), a sulfur-containing amino...

Cite
Malek Mahdavi A, Javadivala Z. A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis. Amino Acids. 2021;53(6):783-800doi: 10.1007/s00726-021-02988-8.
Malek Mahdavi, A., & Javadivala, Z. (2021). A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis. Amino acids, 53(6), 783-800. https://doi.org/10.1007/s00726-021-02988-8
Malek Mahdavi, Aida, and Javadivala, Zeinab. "A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis." Amino acids vol. 53,6 (2021): 783-800. doi: https://doi.org/10.1007/s00726-021-02988-8
Malek Mahdavi A, Javadivala Z. A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis. Amino Acids. 2021 Jun;53(6):783-800. doi: 10.1007/s00726-021-02988-8. Epub 2021 Apr 30. PMID: 33929638.
Copy Download .nbib Format: NLM
Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5.

Molecules (Basel, Switzerland)

Qi Y, Shi L, Duan G, Ma Y, Li P.
PMID: 34885648
Molecules. 2021 Nov 23;26(23). doi: 10.3390/molecules26237066.

Taurochenodeoxycholic acid (TCDCA) is one of the main components of bile acids (BAs). TCDCA has been reported as a signaling molecule, exerting anti-inflammatory and immunomodulatory functions. However, it is not well known whether those effects are mediated by TGR5....

Cite
Qi Y, Shi L, Duan G, et al. Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5. Molecules. 2021;26(23)doi: 10.3390/molecules26237066.
Qi, Y., Shi, L., Duan, G., Ma, Y., & Li, P. (2021). Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5. Molecules (Basel, Switzerland), 26(23), . https://doi.org/10.3390/molecules26237066
Qi, Youchao, et al. "Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5." Molecules (Basel, Switzerland) vol. 26,23 (2021). doi: https://doi.org/10.3390/molecules26237066
Qi Y, Shi L, Duan G, Ma Y, Li P. Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5. Molecules. 2021 Nov 23;26(23). doi: 10.3390/molecules26237066. PMID: 34885648.
Copy Download .nbib Format: NLM
Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5.

Molecules (Basel, Switzerland)

Qi Y, Shi L, Duan G, Ma Y, Li P.
PMID: 34885648
Molecules. 2021 Nov 23;26(23). doi: 10.3390/molecules26237066.

Taurochenodeoxycholic acid (TCDCA) is one of the main components of bile acids (BAs). TCDCA has been reported as a signaling molecule, exerting anti-inflammatory and immunomodulatory functions. However, it is not well known whether those effects are mediated by TGR5....

Cite
Qi Y, Shi L, Duan G, et al. Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5. Molecules. 2021;26(23)doi: 10.3390/molecules26237066.
Qi, Y., Shi, L., Duan, G., Ma, Y., & Li, P. (2021). Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5. Molecules (Basel, Switzerland), 26(23), . https://doi.org/10.3390/molecules26237066
Qi, Youchao, et al. "Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5." Molecules (Basel, Switzerland) vol. 26,23 (2021). doi: https://doi.org/10.3390/molecules26237066
Qi Y, Shi L, Duan G, Ma Y, Li P. Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5. Molecules. 2021 Nov 23;26(23). doi: 10.3390/molecules26237066. PMID: 34885648; PMCID: PMC8659238.
Copy Download .nbib Format: NLM
Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry.

Biotechnology and applied biochemistry

Zheng J, Ye C, Hu B, Yang H, Yao Q, Ma J, Liu Y, Liu H.
PMID: 33140486
Biotechnol Appl Biochem. 2021 Dec;68(6):1332-1341. doi: 10.1002/bab.2055. Epub 2020 Nov 02.

Bile acids (BAs) play a pivotal role in manipulating the development of metabolic diseases. However, due to the compositional complexity and functional variation of BAs, it remains unclear about the changes in BA pool for individuals with obesity or...

Cite
Zheng J, Ye C, Hu B, et al. Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry. Biotechnol Appl Biochem. 2020;68(6):1332-1341doi: 10.1002/bab.2055.
Zheng, J., Ye, C., Hu, B., Yang, H., Yao, Q., Ma, J., Liu, Y., & Liu, H. (2021). Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry. Biotechnology and applied biochemistry, 68(6), 1332-1341. https://doi.org/10.1002/bab.2055
Zheng, Junping, et al. "Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry." Biotechnology and applied biochemistry vol. 68,6 (2021): 1332-1341. doi: https://doi.org/10.1002/bab.2055
Zheng J, Ye C, Hu B, Yang H, Yao Q, Ma J, Liu Y, Liu H. Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry. Biotechnol Appl Biochem. 2021 Dec;68(6):1332-1341. doi: 10.1002/bab.2055. Epub 2020 Nov 02. PMID: 33140486.
Copy Download .nbib Format: NLM
Transcriptome investigation of anti-inflammation and immuno-regulation mechanism of taurochenodeoxycholic acid.

BMC pharmacology & toxicology

Bao L, Hao D, Wang X, He X, Mao W, Li P.
PMID: 33926569
BMC Pharmacol Toxicol. 2021 Apr 29;22(1):23. doi: 10.1186/s40360-021-00491-0.

BACKGROUND: Taurochenodeoxycholic acid (TCDCA) is one of the major active components in bile acid. It was proven to have inhibitory activities on inflammation and also participate in host immuno-regulation. TCDCA exerts anti-inflammatory and immuno-regulatory effects through the glucocorticoid receptor...

Cite
Bao L, Hao D, Wang X, et al. Transcriptome investigation of anti-inflammation and immuno-regulation mechanism of taurochenodeoxycholic acid. BMC Pharmacol Toxicol. 2021;22(1):23doi: 10.1186/s40360-021-00491-0.
Bao, L., Hao, D., Wang, X., He, X., Mao, W., & Li, P. (2021). Transcriptome investigation of anti-inflammation and immuno-regulation mechanism of taurochenodeoxycholic acid. BMC pharmacology & toxicology, 22(1), 23. https://doi.org/10.1186/s40360-021-00491-0
Bao, Lige, et al. "Transcriptome investigation of anti-inflammation and immuno-regulation mechanism of taurochenodeoxycholic acid." BMC pharmacology & toxicology vol. 22,1 (2021): 23. doi: https://doi.org/10.1186/s40360-021-00491-0
Bao L, Hao D, Wang X, He X, Mao W, Li P. Transcriptome investigation of anti-inflammation and immuno-regulation mechanism of taurochenodeoxycholic acid. BMC Pharmacol Toxicol. 2021 Apr 29;22(1):23. doi: 10.1186/s40360-021-00491-0. PMID: 33926569; PMCID: PMC8086280.
Copy Download .nbib Format: NLM
Taurochenodeoxycholic acid inhibits the proliferation and invasion of gastric cancer and induces its apoptosis.

Journal of food biochemistry

Zhang D, Zhu Y, Su Y, Yu M, Xu X, Wang C, Zhang S, Xia L.
PMID: 34278593
J Food Biochem. 2021 Jul 18;e13866. doi: 10.1111/jfbc.13866. Epub 2021 Jul 18.

Taurochenodeoxycholic acid (TCDCA) is the principal ingredient of Compound Shougong Powder. Despite traditional Chinese medicine (TCM) research demonstrates that Compound Shougong Powder can restrict tumor growth, whether TCDCA exerts a role in suppressing cancer as the major ingredient of...

Cite
Zhang D, Zhu Y, Su Y, et al. Taurochenodeoxycholic acid inhibits the proliferation and invasion of gastric cancer and induces its apoptosis. J Food Biochem. 2021;e13866doi: 10.1111/jfbc.13866.
Zhang, D., Zhu, Y., Su, Y., Yu, M., Xu, X., Wang, C., Zhang, S., & Xia, L. (2021). Taurochenodeoxycholic acid inhibits the proliferation and invasion of gastric cancer and induces its apoptosis. Journal of food biochemistry, e13866. https://doi.org/10.1111/jfbc.13866
Zhang, Dongwei, et al. "Taurochenodeoxycholic acid inhibits the proliferation and invasion of gastric cancer and induces its apoptosis." Journal of food biochemistry vol. (2021): e13866. doi: https://doi.org/10.1111/jfbc.13866
Zhang D, Zhu Y, Su Y, Yu M, Xu X, Wang C, Zhang S, Xia L. Taurochenodeoxycholic acid inhibits the proliferation and invasion of gastric cancer and induces its apoptosis. J Food Biochem. 2021 Jul 18;e13866. doi: 10.1111/jfbc.13866. Epub 2021 Jul 18. PMID: 34278593.
Copy Download .nbib Format: NLM
Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry.

Biotechnology and applied biochemistry

Zheng J, Ye C, Hu B, Yang H, Yao Q, Ma J, Liu Y, Liu H.
PMID: 33140486
Biotechnol Appl Biochem. 2020 Nov 02; doi: 10.1002/bab.2055. Epub 2020 Nov 02.

Bile acids (BAs) play a pivotal role in manipulating the development of metabolic diseases. However, due to the compositional complexity and functional variation of BAs, it remains unclear about the changes in BA pool for individuals with obesity or...

Cite
Zheng J, Ye C, Hu B, et al. Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry. Biotechnol Appl Biochem. 2020;doi: 10.1002/bab.2055.
Zheng, J., Ye, C., Hu, B., Yang, H., Yao, Q., Ma, J., Liu, Y., & Liu, H. (2020). Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry. Biotechnology and applied biochemistry, . https://doi.org/10.1002/bab.2055
Zheng, Junping, et al. "Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry." Biotechnology and applied biochemistry vol. (2020). doi: https://doi.org/10.1002/bab.2055
Zheng J, Ye C, Hu B, Yang H, Yao Q, Ma J, Liu Y, Liu H. Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry. Biotechnol Appl Biochem. 2020 Nov 02; doi: 10.1002/bab.2055. Epub 2020 Nov 02. PMID: 33140486.
Copy Download .nbib Format: NLM
Semi-Preparative Isolation and Purification of Three Tauro-Conjugated Cholic Acids from Pulvis Fellis Suis by HSCCC Coupled with ELSD Detection.

Chromatographia

He J, Zhang Y, Ito Y, Sun W.
PMID: 21442029
Chromatographia. 2011;73(3):361-365. doi: 10.1007/s10337-010-1893-2.

Coupled with evaporative light scattering detection, a high-speed counter-current chromatography (HSCCC) method was applied to the separation and purification of three tauro-conjugated cholic acids of taurochenodeoxycholic acid (TCDCA), taurohyodeoxycholic acid (THDCA) and taurohyocholic acid (THCA) from Pulvis Fellis Suis...

Cite
He J, Zhang Y, Ito Y, et al. Semi-Preparative Isolation and Purification of Three Tauro-Conjugated Cholic Acids from Pulvis Fellis Suis by HSCCC Coupled with ELSD Detection. Chromatographia. 2011;73(3):361-365doi: 10.1007/s10337-010-1893-2.
He, J., Zhang, Y., Ito, Y., & Sun, W. (2011). Semi-Preparative Isolation and Purification of Three Tauro-Conjugated Cholic Acids from Pulvis Fellis Suis by HSCCC Coupled with ELSD Detection. Chromatographia, 73(3), 361-365. https://doi.org/10.1007/s10337-010-1893-2
He, Jiao, et al. "Semi-Preparative Isolation and Purification of Three Tauro-Conjugated Cholic Acids from Pulvis Fellis Suis by HSCCC Coupled with ELSD Detection." Chromatographia vol. 73,3 (2011): 361-365. doi: https://doi.org/10.1007/s10337-010-1893-2
He J, Zhang Y, Ito Y, Sun W. Semi-Preparative Isolation and Purification of Three Tauro-Conjugated Cholic Acids from Pulvis Fellis Suis by HSCCC Coupled with ELSD Detection. Chromatographia. 2011;73(3):361-365. doi: 10.1007/s10337-010-1893-2. PMID: 21442029; PMCID: PMC3063647.
Copy Download .nbib Format: NLM
FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats.

Gut

Zhang SY, Li RJW, Lim YM, Batchuluun B, Liu H, Waise TMZ, Lam TKT.
PMID: 33087489
Gut. 2021 Sep;70(9):1675-1683. doi: 10.1136/gutjnl-2020-321757. Epub 2020 Oct 21.

OBJECTIVE: Conjugated bile acids are metabolised by upper small intestinal microbiota, and serum levels of taurine-conjugated bile acids are elevated and correlated with insulin resistance in people with type 2 diabetes. However, whether changes in taurine-conjugated bile acids are...

Cite
Zhang SY, Li RJW, Lim YM, et al. FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats. Gut. 2020;70(9):1675-1683doi: 10.1136/gutjnl-2020-321757.
Zhang, S. Y., Li, R. J. W., Lim, Y. M., Batchuluun, B., Liu, H., Waise, T. M. Z., & Lam, T. K. T. (2021). FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats. Gut, 70(9), 1675-1683. https://doi.org/10.1136/gutjnl-2020-321757
Zhang, Song-Yang, et al. "FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats." Gut vol. 70,9 (2021): 1675-1683. doi: https://doi.org/10.1136/gutjnl-2020-321757
Zhang SY, Li RJW, Lim YM, Batchuluun B, Liu H, Waise TMZ, Lam TKT. FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats. Gut. 2021 Sep;70(9):1675-1683. doi: 10.1136/gutjnl-2020-321757. Epub 2020 Oct 21. PMID: 33087489.
Copy Download .nbib Format: NLM
Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans.

Hepatology communications

Yang Z, Kusumanchi P, Ross RA, Heathers L, Chandler K, Oshodi A, Thoudam T, Li F, Wang L, Liangpunsakul S.
PMID: 30976744
Hepatol Commun. 2019 Feb 20;3(4):542-557. doi: 10.1002/hep4.1322. eCollection 2019 Apr.

Alcoholic liver disease (ALD) develops in a subset of heavy drinkers (HDs). The goals of our study were to (1) characterize the global serum metabolomic changes in well-characterized cohorts of controls (Cs), HDs, and those with alcoholic cirrhosis (AC);...

Cite
Yang Z, Kusumanchi P, Ross RA, et al. Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans. Hepatol Commun. 2019;3(4):542-557doi: 10.1002/hep4.1322.
Yang, Z., Kusumanchi, P., Ross, R. A., Heathers, L., Chandler, K., Oshodi, A., Thoudam, T., Li, F., Wang, L., & Liangpunsakul, S. (2019). Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans. Hepatology communications, 3(4), 542-557. https://doi.org/10.1002/hep4.1322
Yang, Zhihong, et al. "Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans." Hepatology communications vol. 3,4 (2019): 542-557. doi: https://doi.org/10.1002/hep4.1322
Yang Z, Kusumanchi P, Ross RA, Heathers L, Chandler K, Oshodi A, Thoudam T, Li F, Wang L, Liangpunsakul S. Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans. Hepatol Commun. 2019 Feb 20;3(4):542-557. doi: 10.1002/hep4.1322. eCollection 2019 Apr. PMID: 30976744; PMCID: PMC6442705.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries